YS Biopharma Co, Price Prediction
| YSDelisted Stock | 0.48 0.03 5.88% |
Oversold Vs Overbought
33
Oversold | Overbought |
Using YS Biopharma hype-based prediction, you can estimate the value of YS Biopharma Co, from the perspective of YS Biopharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in YS Biopharma to buy its stock at a price that has no basis in reality. In that case, they are not buying YS Biopharma because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
YS Biopharma after-hype prediction price | USD 0.48 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
YS Biopharma |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of YS Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
YS Biopharma After-Hype Price Prediction Density Analysis
As far as predicting the price of YS Biopharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in YS Biopharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of YS Biopharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
YS Biopharma Estimiated After-Hype Price Volatility
In the context of predicting YS Biopharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on YS Biopharma's historical news coverage. YS Biopharma's after-hype downside and upside margins for the prediction period are 0.48 and 0.48, respectively. We have considered YS Biopharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
YS Biopharma is very steady at this time. Analysis and calculation of next after-hype price of YS Biopharma Co, is based on 3 months time horizon.
YS Biopharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as YS Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading YS Biopharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with YS Biopharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 2 Events / Month | 11 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.48 | 0.48 | 0.00 |
|
YS Biopharma Hype Timeline
As of November 22, 2024 YS Biopharma Co, is listed for 0.48. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. YS Biopharma is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on YS Biopharma is about 0.0%, with the expected price after the next announcement by competition of 0.48. About 81.0% of the company outstanding shares are owned by insiders. The book value of YS Biopharma was at this time reported as 5.1. The company recorded a loss per share of 0.56. YS Biopharma Co, had not issued any dividends in recent years. Allowing for the 90-day total investment horizon the next projected press release will be in a few days. Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.YS Biopharma Related Hype Analysis
Having access to credible news sources related to YS Biopharma's direct competition is more important than ever and may enhance your ability to predict YS Biopharma's future price movements. Getting to know how YS Biopharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how YS Biopharma may potentially react to the hype associated with one of its peers.
YS Biopharma Additional Predictive Modules
Most predictive techniques to examine YS Biopharma price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for YS Biopharma using various technical indicators. When you analyze YS Biopharma charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About YS Biopharma Predictive Indicators
The successful prediction of YS Biopharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as YS Biopharma Co,, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of YS Biopharma based on analysis of YS Biopharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to YS Biopharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to YS Biopharma's related companies.
Story Coverage note for YS Biopharma
The number of cover stories for YS Biopharma depends on current market conditions and YS Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that YS Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about YS Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
YS Biopharma Short Properties
YS Biopharma's future price predictability will typically decrease when YS Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of YS Biopharma Co, often depends not only on the future outlook of the potential YS Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. YS Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 93.1 M | |
| Cash And Short Term Investments | 370.1 M |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in YS Biopharma Stock
If you are still planning to invest in YS Biopharma Co, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the YS Biopharma's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |